CANNAPHARMARX, INC.

CPMD ·Healthcare, Drug Manufacturers - General
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $108.9K
Depreciation & Amortization
Depreciation
Amortization
Stock-Based Compensation
Net Cash from Operating Activities $-69.1K
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $69.1K
Net Change in Cash $0
Free Cash Flow
← Newer Page 3 of 3 Older →